zdorПроблемы здоровья и экологииHealth and Ecology Issues2220-09672708-6011Gomel State Medical University10.51523/2708-6011.2005-2-1-20zdor-300Research ArticleКЛИНИЧЕСКАЯ МЕДИЦИНАCLINICAL MEDICINEПРОБЛЕМЫ УСТОЙЧИВОСТИ САЛЬМОНЕЛЛ К КЛИНИЧЕСКИ ЗНАЧИМЫМ АНТИБАКТЕРИАЛЬНЫМ ПРЕПАРАТАМTHE PROBLEMS OF RESISTANCE OF SALMONELLAS TO CLINICALLY SIGNIFICANT ANTIBIOTICSТапальскийД. В.TapalskiD. V.noemail@neicon.ruОсиповВ. А.OsipovV. A.noemail@neicon.ruЖаворонокС. В.ZhavoronokS. V.noemail@neicon.ruТирещенкоЛ. А.TireshchenkoL. A.noemail@neicon.ruШитиковаП. В.ShitikovaP. V.noemail@neicon.ruТорчишникЕ. Н.TorchishnikE. N.noemail@neicon.ruКозловаА. И.KozlovaA. I.noemail@neicon.ruВолченкоА. Н.VolchenkoA. N.noemail@neicon.ruГомельский государственный медицинский университетGomel State Medical UniversityГомельский областной центр гигиены, эпидемиологии и общественного здоровьяGomel Regional Centre of Hygiene, Epidemiology and Public Health20052803200501103110Copyright © Тапальский Д.В., Осипов В.А., Жаворонок С.В., Тирещенко Л.А., Шитикова П.В., Торчишник Е.Н., Козлова А.И., Волченко А.Н., 20052005Тапальский Д.В., Осипов В.А., Жаворонок С.В., Тирещенко Л.А., Шитикова П.В., Торчишник Е.Н., Козлова А.И., Волченко А.Н.Tapalski D.V., Osipov V.A., Zhavoronok S.V., Tireshchenko L.A., Shitikova P.V., Torchishnik E.N., Kozlova A.I., Volchenko A.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.gsmu.by/jour/article/view/300

Представлена информация о распространении антибиотикорезистентности сальмонелл в мире и механизмах устойчивости сальмонелл к клинически значимым антибактериальным препаратам - хинолонам и цефалоспоринам III поколения. Приведены результаты, полученные в ходе микробиологического мониторинга антибиотикорезистентности сальмонелл в Гомельской области. Отмечены высокие уровни устойчивости штаммов S. Typhimurium к цефтриаксону.

The information on antibiotic resistance distribution of Salmonella spp. in the world and mechanisms of Salmonella spp. resistance to clinically significant antibacterial preparations - quinolones and 3rd generation cephalosporins is submitted. The results received during microbiological monitoring of Salmonella spp. drug resistance in the Gomel region are presented. High level resistance of S.Typhimurium strains to ceftriaxon are marked.

сальмонеллыантибиотикорезистентностьхинолоныцефалоспорины 3 поколенияsalmonellasresistance to antibioticsquinolonescephalosporins of 3rd generationсальмонеллыантибиотикорезистентностьхинолоныцефалоспорины 3 поколенияsalmonellasresistance to antibioticsquinolonescephalosporins of 3rd generationReferencesОсипов В.А., Тапальский Д.В. Эпидемиологическое типирование сальмонелл по профилям антибиотикорезистентности. В: Резистентность микроорганизмов к антимикробным препаратам. Материалы международной научно-практической конференции. - Мн., 2003, - С.74-76.Осипов В.А., Тапальский Д.В. Эпидемиологическое типирование сальмонелл по профилям антибиотикорезистентности. В: Резистентность микроорганизмов к антимикробным препаратам. Материалы международной научно-практической конференции. - Мн., 2003, - С.74-76.Осипов В.А., Тапальский Д.В., Красавцев Е.Л. и др. Чувствительность к антибактериальным препаратам шигелл и сальмонелл, циркулирующих в Гомельской области, и некоторые аспекты организации мониторинга антибиотикорезистентности. Медицинские новости. 2003; 11: 105-108.Осипов В.А., Тапальский Д.В., Красавцев Е.Л. и др. Чувствительность к антибактериальным препаратам шигелл и сальмонелл, циркулирующих в Гомельской области, и некоторые аспекты организации мониторинга антибиотикорезистентности. Медицинские новости. 2003; 11: 105-108.Сидоренко С.В., Тишков В.И. Молекулярные основы резистентности к антибиотикам. Успехи биологической химии. 2004; 44: 263-306.Сидоренко С.В., Тишков В.И. Молекулярные основы резистентности к антибиотикам. Успехи биологической химии. 2004; 44: 263-306.Тапальский Д.В., Жаворонок С.В., Осипов В.А., Нараленков В.А., Титов Л.П., Ермакова Т.А. Система микробиологического мониторинга в политике планирования антимикробной химиотерапии. Рецепт. 2003; 5; Прил. 1: 50-53.Тапальский Д.В., Жаворонок С.В., Осипов В.А., Нараленков В.А., Титов Л.П., Ермакова Т.А. Система микробиологического мониторинга в политике планирования антимикробной химиотерапии. Рецепт. 2003; 5; Прил. 1: 50-53.Aarestrup F.M., Wiuff C., Molbak K., Threlfall E.J. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob Agents Chemother 2003; 47:827-829.Aarestrup F.M., Wiuff C., Molbak K., Threlfall E.J. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob Agents Chemother 2003; 47:827-829.Aarestrup F.M., Wiuff C., Molbak K., Threlfall E.J. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob Agents Chemother 2003; 47:827-829.Aarestrup F.M., Wiuff C., Molbak K., Threlfall E.J. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob Agents Chemother 2003; 47:827-829.Albayrak F., Cokca F., Erdem B., Aysev A.D. Predictive value of nalidixic acid resistance for detecting salmonellae with decreased ciprofloxacin susceptibility. International Journal of Antimicrobial Agents 2004; 23: 332-336.Albayrak F., Cokca F., Erdem B., Aysev A.D. Predictive value of nalidixic acid resistance for detecting salmonellae with decreased ciprofloxacin susceptibility. International Journal of Antimicrobial Agents 2004; 23: 332-336.Boyd D., Cloeckaert A., Chaslus-Danela E., Mulvey M.R. Characterization of variant Salmonella Genomic Island 1 multidrug resistance regions from serovars Typhimurium DT104 and Agona. Antimicrob Agents Chemother 2002; 46:1714-1722.Boyd D., Cloeckaert A., Chaslus-Danela E., Mulvey M.R. Characterization of variant Salmonella Genomic Island 1 multidrug resistance regions from serovars Typhimurium DT104 and Agona. Antimicrob Agents Chemother 2002; 46:1714-1722.Davis M.A., Hancock D.D., Besser T.E. Multiresistant clones of Salmonella enterica: the importance of dissemination. J Lab Clin Med 2002; 140:135-141.Davis M.A., Hancock D.D., Besser T.E. Multiresistant clones of Salmonella enterica: the importance of dissemination. J Lab Clin Med 2002; 140:135-141.Doublet B., Lailler R., Meunier D, et al. Variant Salmonella genomic island 1 antibiotic resistance gene cluster in Salmonella enterica serovar Albany. Emerg Infect Dis 2003; 9:585-591.Doublet B., Lailler R., Meunier D, et al. Variant Salmonella genomic island 1 antibiotic resistance gene cluster in Salmonella enterica serovar Albany. Emerg Infect Dis 2003; 9:585-591.Gales A.C., Sader H.S., Mendes R.E., Jones R.N. Salmonella spp. isolates causing bloodstream infections in Latin America: report of antimicrobial activity from SENTRY antimicrobial surveillance program (1997-2000). Diag Microbiol Infect Dis 2002; 44:313-318.Gales A.C., Sader H.S., Mendes R.E., Jones R.N. Salmonella spp. isolates causing bloodstream infections in Latin America: report of antimicrobial activity from SENTRY antimicrobial surveillance program (1997-2000). Diag Microbiol Infect Dis 2002; 44:313-318.Hanson N.D., Moland E.S., Hossain A. et al. Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 β-lactamases. J Antimicrob Chemother 2002; 49:1011-1014.Hanson N.D., Moland E.S., Hossain A. et al. Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 β-lactamases. J Antimicrob Chemother 2002; 49:1011-1014.Helms M., Vastrup P., Gerner-Smidt P., Molbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella Typhimurium. Emerg Infect Dis 2002; 8:490-495.Helms M., Vastrup P., Gerner-Smidt P., Molbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella Typhimurium. Emerg Infect Dis 2002; 8:490-495.Lindsay E.A., Lawson A.J., Walker R.A. et al. Molecular characterisation of a multiresistant strain of Salmonella enterica serotype Typhimurium DT204b responsible for an international outbreak of salmonellosis: importance of electronic exchange of gel data for outbreak investigations. Emerg Infect Dis 2002; 8:732-734.Lindsay E.A., Lawson A.J., Walker R.A. et al. Molecular characterisation of a multiresistant strain of Salmonella enterica serotype Typhimurium DT204b responsible for an international outbreak of salmonellosis: importance of electronic exchange of gel data for outbreak investigations. Emerg Infect Dis 2002; 8:732-734.Molbak K, Gerner-Smidt, Wegener HC. Increasing quinolone resistance in Salmonella enterica serotype Enteritidis. Emerg Infect Dis 2002; 8:514-515.Molbak K, Gerner-Smidt, Wegener HC. Increasing quinolone resistance in Salmonella enterica serotype Enteritidis. Emerg Infect Dis 2002; 8:514-515.Nakaya H., Yasuhara A., Yoshimura K. et al. Life-threatening infantile diarrhoea from fluoroquinolone resistant Salmonella enterica Typhimurium with mutations in both gyrA and parC. Emerg Infect Dis 2003; 9:255-257.Nakaya H., Yasuhara A., Yoshimura K. et al. Life-threatening infantile diarrhoea from fluoroquinolone resistant Salmonella enterica Typhimurium with mutations in both gyrA and parC. Emerg Infect Dis 2003; 9:255-257.National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing; M 100 - S12 for use with M2-A7 - disk diffusion. 2002; 22(1).National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing; M 100 - S12 for use with M2-A7 - disk diffusion. 2002; 22(1).Parry C.M. Antimicrobial drug resistance in Salmonella enterica. Current Opinion in Infectious Diseases 2003; 16:467-472.Parry C.M. Antimicrobial drug resistance in Salmonella enterica. Current Opinion in Infectious Diseases 2003; 16:467-472.Pessoa-Silva C.L., Toscano C.M., Moreira B.M. et al. Infection due to extended- spectrum β-lactamase-producing Salmonella enterica subsp. enterica serotype Infantis in a neonatal unit. J Pediatr 2002; 141:381-387.Pessoa-Silva C.L., Toscano C.M., Moreira B.M. et al. Infection due to extended- spectrum β-lactamase-producing Salmonella enterica subsp. enterica serotype Infantis in a neonatal unit. J Pediatr 2002; 141:381-387.Popoff M.Y., Minor L. Le. Antigenic Formulas of the Salmonella Serovars, 8th revision. WHO Collaborating Centre for Reference and Research on Salmonella, Institut Pasteur, Paris, 2001.Popoff M.Y., Minor L. Le. Antigenic Formulas of the Salmonella Serovars, 8th revision. WHO Collaborating Centre for Reference and Research on Salmonella, Institut Pasteur, Paris, 2001.Poppe C., Ziebell K., Martin L., Allen K. Diversity in antimicrobial resistance and other characteristics among Salmonella Typhimurium DT104 isolates. Microb Drug Resist 2002; 8:107-122.Poppe C., Ziebell K., Martin L., Allen K. Diversity in antimicrobial resistance and other characteristics among Salmonella Typhimurium DT104 isolates. Microb Drug Resist 2002; 8:107-122.Rabatsky-Her T., Whichard J., Rossiter S. et al. Multidrug-resistant strains of Salmonella enterica Typhimurium, United States, 1997-1998. Emerg. Infect. Dis. 2004; 10: 795-801.Rabatsky-Her T., Whichard J., Rossiter S. et al. Multidrug-resistant strains of Salmonella enterica Typhimurium, United States, 1997-1998. Emerg. Infect. Dis. 2004; 10: 795-801.Rankin S.C., Aceto H., Cassidy J. et al. Molecular characterization of cephalosporin-resistant Salmonella enterica serotype Newport isolates from animals in Pennsylvania. J Clin Microbiol 2002; 40:4679-4684.Rankin S.C., Aceto H., Cassidy J. et al. Molecular characterization of cephalosporin-resistant Salmonella enterica serotype Newport isolates from animals in Pennsylvania. J Clin Microbiol 2002; 40:4679-4684.Ribot E.M., Wierzba R.K., Angulo F.J., Barrett T.J. Salmonella enterica serotype Typhimurium DT104 isolated from humans, United States, 1985, 1990, and 1995. Emerg Infect Dis 2002; 8:387-391.Ribot E.M., Wierzba R.K., Angulo F.J., Barrett T.J. Salmonella enterica serotype Typhimurium DT104 isolated from humans, United States, 1985, 1990, and 1995. Emerg Infect Dis 2002; 8:387-391.Ruiz M., Rodríguez J.C., Sirvent E. et al. Usefulness of different techniques in the study of the epidemiology of salmonellosis. APMIS 2003; 111: 848-856.Ruiz M., Rodríguez J.C., Sirvent E. et al. Usefulness of different techniques in the study of the epidemiology of salmonellosis. APMIS 2003; 111: 848-856.Threlfall E.J. Antimicrobial drug resistance in Salmonella: problems and perspectives in food- and water-borne infections. FEMS Microbiol Rev 2002; 26:141-148.Threlfall E.J. Antimicrobial drug resistance in Salmonella: problems and perspectives in food- and water-borne infections. FEMS Microbiol Rev 2002; 26:141-148.Threlfall E.J., Fisher I.S.T., Berghold C. et al. Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of international multi-centre surveillance. Eurosurveillance 2003; 8:41-45.Threlfall E.J., Fisher I.S.T., Berghold C. et al. Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of international multi-centre surveillance. Eurosurveillance 2003; 8:41-45.WHO Global Salm-Surv External Quality Assurance System (EQAS) [Electronic resource]. - 2003. - Mode of access: http://www.who.int/salmsurv/enWHO Global Salm-Surv External Quality Assurance System (EQAS) [Electronic resource]. - 2003. - Mode of access: http://www.who.int/salmsurv/enWHONET 5. Microbiology Laboratory Database Software. World Health Organization, Geneva, Switzerland, 1999.WHONET 5. Microbiology Laboratory Database Software. World Health Organization, Geneva, Switzerland, 1999.World Health Organization. WHO Global Strategy for Containment of Antimicrobial Resistance. Geneva, 2001. WHO/CDS/CSR/DRS/2001.2.World Health Organization. WHO Global Strategy for Containment of Antimicrobial Resistance. Geneva, 2001. WHO/CDS/CSR/DRS/2001.2.

The authors declare that there are no conflicts of interest present.